No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Fostair is a combination drug used in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients: formoterol fumarate dihydrate, a long-acting beta-2 agonist, and beclometasone dipropionate, an inhaled corticosteroid. Fostair is used to reduce inflammation in the airways and to open them up, allowing more air to flow through. It is available in a metered-dose inhaler, a dry powder inhaler, and a nebulizer solution.
Fostair is a widely used drug in the respiratory market, with its combination of two active ingredients providing a more effective treatment than either drug alone. It is used to treat both acute and chronic respiratory conditions, and is often prescribed as a maintenance therapy to prevent exacerbations.
Companies in the Fostair market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Merck, and Novartis. Show Less Read more
